| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.26▲ | 0.25▲ | 0.25▲ | 0.28▼ | 0.30▼ |
| MA10 | 0.25▲ | 0.25▲ | 0.27▼ | 0.28▼ | 0.37▼ |
| MA20 | 0.27▼ | 0.27▼ | 0.28▼ | 0.30▼ | 0.52▼ |
| MA50 | 0.29▼ | 0.30▼ | 0.33▼ | 0.39▼ | 0.66▼ |
| MA100 | 0.36▼ | 0.40▼ | 0.43▼ | 0.52▼ | 3.91▼ |
| MA200 | 0.50▼ | 0.57▼ | 0.58▼ | 0.59▼ | 104.25▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | 0.002▲ | 0.001▲ | 0.002▲ | 0.024▲ |
| RSI | 46.490▼ | 44.967▼ | 42.492▼ | 34.645▼ | 31.352▼ |
| STOCH | 48.873 | 33.279 | 18.750▼ | 48.375 | 8.101▼ |
| WILL %R | -50.000 | -59.722 | -59.722 | -64.246 | -93.161▼ |
| CCI | 28.259 | -6.193 | -34.598 | -122.990▼ | -118.692▼ |
|
Wednesday, April 30, 2025 05:59 AM
Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, ...
|
|
Thursday, April 17, 2025 03:04 PM
1 Day HSDT -1.79% DJIA -1.33% Russell 2K 0.00% Health Care/Life Sciences -0.86% ...
|
|
Friday, April 11, 2025 11:35 PM
NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) announced it has exceeded its initial enrollment target for the stroke registrational program evaluating its Portable ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/05/25 | 0.244 | 0.2799 | 0.2375 | 0.2601 | 260,651 |
| 30/04/25 | 0.2555 | 0.2555 | 0.2212 | 0.24 | 319,591 |
| 29/04/25 | 0.307 | 0.307 | 0.2839 | 0.2839 | 51,878 |
| 28/04/25 | 0.31 | 0.31 | 0.285 | 0.2993 | 73,832 |
| 25/04/25 | 0.31 | 0.31 | 0.2803 | 0.292 | 83,369 |
| 24/04/25 | 0.30 | 0.31 | 0.295 | 0.296 | 25,335 |
| 23/04/25 | 0.295 | 0.3052 | 0.295 | 0.295 | 30,737 |
| 22/04/25 | 0.275 | 0.291 | 0.2635 | 0.272 | 55,367 |
| 21/04/25 | 0.2998 | 0.2999 | 0.26 | 0.27 | 81,915 |
| 17/04/25 | 0.2801 | 0.2849 | 0.2744 | 0.275 | 50,236 |
|
|
||||
|
|
||||
|
|